HTA17 Comparison of Methods for Modelling the Cost-Effectiveness of Atezolizumab as an Adjuvant Treatment in Stage II-IIIA Non-Small Cell Lung Cancer
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.1702
https://www.valueinhealthjournal.com/article/S1098-3015(23)04832-5/fulltext
Title :
HTA17 Comparison of Methods for Modelling the Cost-Effectiveness of Atezolizumab as an Adjuvant Treatment in Stage II-IIIA Non-Small Cell Lung Cancer
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)04832-5&doi=10.1016/j.jval.2023.09.1702
First page :
Section Title :
Open access? :
No
Section Order :
11150